Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.135
+0.005 (0.16%)
Apr 9, 2026, 12:51 PM EDT - Market open
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $238.15 million as of April 9, 2026. Its market cap has increased by 10.17% in one year.
Market Cap
238.15M
Enterprise Value
105.08M
1-Year Change
10.17%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $238.15M, an increase of 433.26%. That is a compound annual growth rate of 20.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 237.77M | 109.54% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 244.29M |
| Cellectis | 242.59M |
| Arcturus Therapeutics Holdings | 241.88M |
| Camp4 Therapeutics | 241.42M |
| Keros Therapeutics | 241.34M |
| ALX Oncology Holdings | 240.84M |
| Context Therapeutics | 240.72M |
| Voyager Therapeutics | 236.01M |